Aboveallislove
Super Moderator
I'll be doing a detailed comment to the FDA for the combo for approval, but thought it would be good to have one with as many folks signing as possible. I'm wondering if Jeannie could put together here or somewhere a "petition" type thing where folks can sign their real names connection to CF, etc. (while maintaining anon. they have here). (I.E. Joe SixPack, 40 ddf508, Chicago, Illinois). Or if someone else can do if Jeannie can't. I draft the following which is rough. My goal was to keep it both short and non-controversial so everyone would feel comfortable signing, but my language might not be the best. ...writers block this am!!
Needs to be in by end of April, but once we get "final" language and it posted somewhere, if we could get it published here and all the other support places folks use for signatures then we could really hit the FDA with the voice of the CF community.
Pulmonary-Allergy Drug Advisory Committee
Docket No. FDA-2015-N-0001
NDA 206038
We, the undersigned, are individuals suffering from Cystic Fibrosis and/or their caregivers and loved ones. We write in support of the NDA for lumacaftor/ivacaftor and strongly urge the Committee to recommend this drug to the FDA for approval.
We recognize that the average FEV improvement shown in clinical trials is modest when compared to ivacaftor, but even a modest improvement in FEV, when living with a degenerative disease, is a huge benefit. Further, this drug offers the chance for patients to remain stable until better drugs are available. Moreover, in reviewing the NDA, we urge the Committee to consider the very real benefit this drug offers to those with Cystic Fibrosis in the form of reduced exacerbations, improved weight, and overall improved quality of life.
Submitted by CysticFibrosis.com, on behalf of its members and the undersigned:
Needs to be in by end of April, but once we get "final" language and it posted somewhere, if we could get it published here and all the other support places folks use for signatures then we could really hit the FDA with the voice of the CF community.
Pulmonary-Allergy Drug Advisory Committee
Docket No. FDA-2015-N-0001
NDA 206038
We, the undersigned, are individuals suffering from Cystic Fibrosis and/or their caregivers and loved ones. We write in support of the NDA for lumacaftor/ivacaftor and strongly urge the Committee to recommend this drug to the FDA for approval.
We recognize that the average FEV improvement shown in clinical trials is modest when compared to ivacaftor, but even a modest improvement in FEV, when living with a degenerative disease, is a huge benefit. Further, this drug offers the chance for patients to remain stable until better drugs are available. Moreover, in reviewing the NDA, we urge the Committee to consider the very real benefit this drug offers to those with Cystic Fibrosis in the form of reduced exacerbations, improved weight, and overall improved quality of life.
Submitted by CysticFibrosis.com, on behalf of its members and the undersigned: